Medico Remedies has commenced work for new factory for manufacturing of B lactum tablets, capsules, dry syrup and injections (including amoxycillin and clauvulinic acid formulations). This plant will have capacity of 25 million tablets, 45 million capsules,10 million dry syrups, 10 million injectables. The investment required for this capacity is Rs 30 crore. The proposed capacity is to be added within 2 years.
The state-of-the-art facility in going to be made as per PIC/S guidelines. It is expected to add about 25 crore revenue after receiving all approvals.
Medico Remedies is a leading manufacturer and exporter of pharmaceutical formulations including tablets, capsules and suspensions.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1792.40 |
| Dr. Reddys Lab | 1279.55 |
| Cipla | 1385.00 |
| Zydus Lifesciences | 1100.10 |
| Lupin | 2269.85 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: